High Point Advisor Group LLC Fulgent Genetics, Inc. Transaction History

High Point Advisor Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $257,412 - $336,653	-5,365 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $149,365 - $221,185	-1,995 Reduced 27.11%	5,365 $483,000
Q2 2021 Jul 29, 2021	SELL	$66.8 - $100.45 $162,658 - $244,595	-2,435 Reduced 24.86%	7,360 $679,000
Q1 2021 Apr 12, 2021	BUY	$59.3 - $183.85 $88,060 - $273,017	1,485 Added 17.87%	9,795 $837,000
Q4 2020 Feb 10, 2021	BUY	$31.01 - $52.1 $257,693 - $432,951	8,310 New	8,310 $1.53 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $523M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.